Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pentoxifylline and skin inflammation

I Bruynzeel1, T J Stoof, R Willemze

  • 1Department of Dermatology, Free University Hospital, Amsterdam, The Netherlands.

Clinical and Experimental Dermatology
|January 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapamycin impairs UV induction of mutant-p53 overexpressing cell clusters without affecting tumor onset.

International journal of cancer·2011
Same author

Human allo-reactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia.

Leukemia·2011
Same author

Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40.

Leukemia·2011
Same author

Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia.

Leukemia·2011
Same author

Point and period prevalences of eczema in rural and urban schoolchildren in Ghana, Gabon and Rwanda.

Journal of the European Academy of Dermatology and Venereology : JEADV·2011
Same author

Quantitative expression profiling of G-protein-coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target.

Pigment cell & melanoma research·2010
Same journal

The evolving understanding of prurigo nodularis.

Clinical and experimental dermatology·2026
Same journal

Cutaneous inflammatory biomarkers in rosacea and their association with disease severity.

Clinical and experimental dermatology·2026
Same journal

A slowly enlarging pink nodular lesion with arborizing vessels on the scalp.

Clinical and experimental dermatology·2026
Same journal

Guselkumab for checkpoint inhibitor-exacerbated psoriasis in a patient with metastatic melanoma.

Clinical and experimental dermatology·2026
Same journal

Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort.

Clinical and experimental dermatology·2026
Same journal

A second case of recessive mosaicism in ABCA12 causing a congenital unilateral epidermal nevus.

Clinical and experimental dermatology·2026
See all related articles

Pentoxifylline, a cyclic nucleotide phosphodiesterase inhibitor, offers benefits for inflammatory skin conditions. It modulates key factors like cytokines and cell adhesion involved in skin inflammation.

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Cyclic nucleotide phosphodiesterase inhibitors demonstrate therapeutic potential in inflammatory skin diseases.
  • Pentoxifylline is a notable example within this drug class.

Purpose of the Study:

  • To discuss the biological effects of pentoxifylline in the context of skin inflammation.
  • To explore pentoxifylline's impact on key inflammatory mediators and cellular interactions.

Main Methods:

  • Review of existing literature on pentoxifylline's mechanisms in skin inflammation.
  • Analysis of pentoxifylline's effects on cytokine production.
  • Examination of pentoxifylline's influence on leukocyte-endothelial and leukocyte-keratinocyte adhesion.

Related Experiment Videos

Main Results:

  • Pentoxifylline beneficially influences numerous inflammatory skin diseases.
  • The drug impacts the production of proinflammatory cytokines and chemokines.
  • Pentoxifylline affects leukocyte-endothelial cell adhesion and leukocyte-keratinocyte adhesion in inflammatory skin conditions.

Conclusions:

  • Pentoxifylline exhibits a beneficial role in managing inflammatory skin diseases through modulation of key inflammatory pathways.
  • Understanding these mechanisms can guide therapeutic strategies for skin inflammation.